Fosun International and Get in the Ring are looking for startups with innovative approaches and solutions in the health sector, that significantly increase the families’ quality of life and well-being. Are you ready to validate and grow your solution with Fosun, and pave the way for innovation in the Asia-pacific health market?
Fosun International Limited is a family-focused multinational company that has been listed on the main board of the Hong Kong Stock Exchange (00656:HK) since 2007. Founded in 1992, Fosun’s total assets exceed RMB500 billion (c.US$75 billion). With its roots in China, and through technology and innovation, Fosun’s mission is to create customer-to-maker (C2M) ecosystems in health, happiness and wealth, providing high-quality products and services for families around the world.
Their pharmaceuticals and healthcare segment is involved in the research and development, manufacturing, and sale & trading of pharmaceutical and healthcare products worldwide. Its portfolio includes subsidiaries such as Fosun Pharma, Henlius, United Family Healthcare, hospital group Luz Saude, and pharmaceutical company Gland Pharma.
Do you want to get a foothold in the APAC region? Do you have a solution that is ready to be tested? And are you ready to pitch your company to the most relevant Fosun subsidiaries & investors?
复星国际有限公司是一家专注于跨国企业，该公司已经于 2007 年在香港证券交易所主板上市（00656，HK）。复星集团公司成立于 1992 年，公司总资产超过 5000 亿元（约 750 亿美元）。复星集团的使命是通过其在中国的根基，通过技术和创新，创造客户与制造商（C2M）在健康、幸福和财富生态系统的对接，为世界各地的家庭提供高品质的产品和服务。其医药和保健行业参与了全球医药和保健产品的研发、制造、销售和交易。其投资组合包括子公司如复星医药、Henlius、睦家医疗集团、Luz Saude 医院集团和 Gland Pharma 制药公司。
The deadline for this Challenge has passed, please check out our other Challenges
Fosun is looking for innovative solutions in the health sector, that prevent and treat diseases and increase the quality of life and well-being. Out of the diverse Fosun portfolio, the subsidiaries supporting this challenge are; Fosun Pharma, Henlius Biotech, Chindex Medical Limited and United Family Healthcare. They are in search of technology-driven startups, which use for example artificial intelligence, virtual reality, machine learning, 3d printing & nanotechnology, or Big Data & analytics. Fields of interest include:
复星集团正在寻找卫生行业的创新解决方案，以预防和治疗疾病，提高生活质量和福利。在多元化的复星投资组合中，得到了子公司复星医药、Henlius 生物科技、中国医药有限公司和联合家庭医疗公司对这一挑战的支持。他们在寻找技术驱动的初创公司，例如人工智能、虚拟现实、机器学习、3D 打印和纳米技术、或大数据及数据分析。他们感兴趣的领域包括：
Innovate the way how drugs are manufactured, including research, development, testing, and production.
PHARMACEUTICAL DISTRIBUTION & RETAIL
Use new technologies to distribute and market pharmaceutics. An example can be a new technology that improves health care at a distance.
Innovate the way healthcare services are offered. For example, innovations which can benefit the elderly in the growing senior care segment.
DIAGNOSIS PRODUCTS & MEDICAL DEVICES
Offer new products and devices which help prevent and treat diseases. For example, a novel product which helps diagnose chronic diseases in one of the Fosun hospital chains.
WHAT'S IN IT FOR YOU
The most promising startups are invited to join the multiple day matchmaking event in Shanghai, and get access to the impressive Fosun network of subsidiaries and investors. Be ready to:
Spend 2 full days of one-on-one sessions with decision makers & experts
Take part in the field visits to multiple Fosun subsidiaries
Explore business opportunities and get industry insights in the Asia-Pacific health market
Pitch your solution for some of the largest global investors
Get the chance to roll out a pilot with one of the Fosun subsidiaries
Have a working prototype or demonstrator
Be able to launch a finished product or service within the next year
Expected availability to be present in Shanghai during pilot phase
花 2 整天的时间与决策者和专家进行一对一的会谈
The deadline for applications is March 25th.
ANNOUNCEMENT SELECTED STARTUPS
Between 5-15 startups will be invited to the matchmaking days to talk business.
选定的初创公司公告（将邀请 5-15 家初创公司）
2 DAY MATCHMAKING EVENT
The matchmaking days will take place in Shanghai. The most relevant startup(s) will be awarded with a pilot program.